Basu-Roy et al. proved that downregulating SOX2 restrained tumorigenesis in osteosarcoma, and cells with lowered SOX2 levels were not able to form osteospheres and differentiate into mature osteoblasts any further14. This evidence concerns the gene SOX2 and osteosarcoma.